Yu Hu

10.5k total citations
58 papers, 1.1k citations indexed

About

Yu Hu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Yu Hu has authored 58 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 23 papers in Cancer Research and 9 papers in Surgery. Recurrent topics in Yu Hu's work include MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (11 papers) and Circular RNAs in diseases (8 papers). Yu Hu is often cited by papers focused on MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (11 papers) and Circular RNAs in diseases (8 papers). Yu Hu collaborates with scholars based in China, United States and Germany. Yu Hu's co-authors include Qin Zhu, Kejing Zhang, Lu Tang, Zhinan Yin, Heng Mei, Lili Tang, Xin Li, Bo Liu, Na Luo and Qin Lu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Yu Hu

55 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Hu China 20 603 411 211 182 137 58 1.1k
Jinpeng Li China 20 678 1.1× 299 0.7× 173 0.8× 232 1.3× 161 1.2× 77 1.5k
Jing Tao China 13 262 0.4× 174 0.4× 242 1.1× 186 1.0× 65 0.5× 28 729
Layla Shojaie United States 14 373 0.6× 220 0.5× 103 0.5× 176 1.0× 91 0.7× 34 921
Mingxiang Ye China 17 596 1.0× 266 0.6× 261 1.2× 226 1.2× 117 0.9× 31 1.1k
Srinivas Chava United States 20 614 1.0× 400 1.0× 47 0.2× 154 0.8× 73 0.5× 41 1.2k
Hikmet Akkız Türkiye 23 505 0.8× 340 0.8× 150 0.7× 231 1.3× 83 0.6× 73 1.4k
Xiaohong Xiang China 23 763 1.3× 471 1.1× 177 0.8× 60 0.3× 162 1.2× 71 1.3k
Zhenwei Yang China 13 208 0.3× 107 0.3× 201 1.0× 106 0.6× 70 0.5× 35 618

Countries citing papers authored by Yu Hu

Since Specialization
Citations

This map shows the geographic impact of Yu Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Hu more than expected).

Fields of papers citing papers by Yu Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Hu. The network helps show where Yu Hu may publish in the future.

Co-authorship network of co-authors of Yu Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Hu. A scholar is included among the top collaborators of Yu Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Hu. Yu Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Yu, et al.. (2025). Exploring the role of OIP5-AS1 in the mechanisms of delayed fracture healing: functional insights and clinical implications. Journal of Orthopaedic Surgery and Research. 20(1). 32–32. 1 indexed citations
2.
Zhang, Tong, Di Yang, Liang Tang, & Yu Hu. (2024). Current development of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies (Review). Molecular Medicine Reports. 30(2). 2 indexed citations
4.
Hu, Yu, et al.. (2024). Prevalence of frailty in senile osteoporosis: A systematic review and meta-analysis. Archives of Gerontology and Geriatrics. 130. 105718–105718.
5.
Zhu, Qin, Yukun Cao, Jiaqi Yuan, & Yu Hu. (2024). Adipose-derived stem cell exosomes promote tumor characterization and immunosuppressive microenvironment in breast cancer. Cancer Immunology Immunotherapy. 73(2). 39–39. 8 indexed citations
6.
Li, Xia, Bingxin Sun, Yunjian Zhang, et al.. (2023). Research on the relationship between architectural features in northeast China and vertical aerosol transmission of COVID-19. Frontiers in Public Health. 10. 1052610–1052610. 3 indexed citations
7.
Luo, Yong, Shan Liu, Ning Yang, et al.. (2023). circ_0001274 Competitively Binds miR-143-3p to Upregulate VWF Expression to Improve Acute Traumatic Coagulopathy. Oxidative Medicine and Cellular Longevity. 2023. 1–18. 2 indexed citations
8.
Hu, Yu, et al.. (2023). A feedback loop between lncRNA MALAT1 and DNMT1 promotes triple-negative breast cancer stemness and tumorigenesis. Cancer Biology & Therapy. 24(1). 2235768–2235768. 8 indexed citations
9.
Wang, Dongdong, Meili Sun, Peng Yan, et al.. (2023). Value of CT‐based radiomics in evaluating the response of bone metastases to systemic drug therapy in breast cancer patients. Thoracic Cancer. 15(5). 361–368. 4 indexed citations
10.
Dierickx, Daan, Richard Schäfer, Marienn Réti, et al.. (2023). Safety and performance of theSpectraOptia apheresis system for white blood cell depletion in patients with elevated white blood cell counts. Journal of Clinical Apheresis. 38(4). 396–405. 1 indexed citations
11.
Mao, Liang, Yun‐Da Li, Gang� Li, et al.. (2022). Heart-targeting exosomes from human cardiosphere-derived cells improve the therapeutic effect on cardiac hypertrophy. Journal of Nanobiotechnology. 20(1). 435–435. 26 indexed citations
12.
Luan, Chao, et al.. (2022). Whole-genome identification and construction of the lncRNA-mRNA co-expression network in patients with actinic keratosis. Translational Cancer Research. 11(11). 4070–4078. 3 indexed citations
13.
Cai, Li, et al.. (2021). Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models. Frontiers in Oncology. 11. 639528–639528. 16 indexed citations
14.
Hu, Yu, et al.. (2021). The Mutual Inhibition of FoxO1 and SREBP‐1c Regulated the Progression of Hepatoblastoma by Regulating Fatty Acid Metabolism. Mediators of Inflammation. 2021(1). 5754592–5754592. 6 indexed citations
15.
Cai, Zhou, et al.. (2021). RUNX2 promotes vascular injury repair by activating miR-23a and inhibiting TGFBR2. Annals of Translational Medicine. 9(5). 363–363. 5 indexed citations
16.
Zhu, Qin, Xian Zhang, Hongyan Zai, et al.. (2020). circSLC8A1 sponges miR-671 to regulate breast cancer tumorigenesis via PTEN/PI3k/Akt pathway. Genomics. 113(1). 398–410. 30 indexed citations
17.
Pan, Feng, Lian Yang, Yuncheng Li, et al.. (2020). Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study. International Journal of Medical Sciences. 17(9). 1281–1292. 154 indexed citations
18.
19.
Wang, Chengzhi, Xiaoqing Zhou, Hongjuan Xu, et al.. (2018). Niclosamide Inhibits Cell Growth and Enhances Drug Sensitivity of Hepatocellular Carcinoma Cells via STAT3 Signaling Pathway. Journal of Cancer. 9(22). 4150–4155. 35 indexed citations
20.
Lü, Weiguo, et al.. (2008). Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province, China. International Journal of Gynecological Cancer. 18(1). 104–109. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026